Apoptosis and DNA fragmentation precede TNF‐induced cytolysis in U937 cells

The hypothesis that activation of apoptosis and DNA fragmentation is involved in TNF‐mediated cytolysis of U937 tumor cells was investigated. Morphological, biochemical, and kinetic criteria established that TNF activates apoptosis as opposed to necrosis. Within 2–3 h of exposure to TNF, U937 underwent the morphological alterations characteristic of apoptosis. This was accompanied by cleavage of DNA into multiples of nucleosome size fragments. Both of these events occurred 1–2 h prior to cell death as defined by trypan blue exclusion of 51Cr release. DNA fragmentation was not a non‐specific result of cell death since U937 cells lysed under hypotonic conditions did not release DNA fragments. The percentage of cells undergoing apoptosis depended on the concentration of TNF and was augmented by the addition of cycloheximide. A TNF‐resistant variant derived from U937 did not undergo apoptosis in response to TNF, even in the presence of cycloheximide. Furthermore, TNF could still activate NFkB in this variant, suggesting that this pathway is not involved in TNF‐mediated cytotoxicity. Two agents known to inhibit TNF‐mediated cytotoxicity, ZnSo4, and 3‐aminobenzamide, were shown to inhibit TNF‐induced apoptosis. Taken altogether, these data support the hypothesis that activation of apoptosis is at least one essential step in the TNF lytic pathway in the U937 model system.

[1]  J. Larrick,et al.  Cytotoxic mechanism of tumor necrosis factor‐α , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  W. Bursch,et al.  The biochemistry of cell death by apoptosis. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[3]  D. Green,et al.  Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. , 1990, Journal of immunology.

[4]  T. Tadakuma,et al.  T cell receptor-mediated DNA fragmentation and cell death in T cell hybridomas. , 1990, Journal of immunology.

[5]  G. Riethmüller,et al.  Zn++ inhibits both tumor necrosis factor‐mediated DNA fragmentation and cytolysis , 1989, International journal of cancer.

[6]  A. Fauci,et al.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Scuderi,et al.  Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells. , 1989, Cancer research.

[8]  S. Orrenius,et al.  Calcium-activated DNA fragmentation in rat liver nuclei. , 1989, The Journal of biological chemistry.

[9]  C. Dinarello,et al.  Monokines and Other Non-Lymphocytic Cytokines , 1989 .

[10]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Kuriyama,et al.  Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. , 1989, Cancer research.

[12]  S. A. Leadon,et al.  Recombinant Human Tumor Necrosis Factor by in Vitro Oxidative Damage in Murine Tumor Cells Treated Updated Version Citing Articles E-mail Alerts Oxidative Damage in Murine Tumor Cells Treated in Vitro by Recombinant Human Tumor Necrosis Factor1 , 2022 .

[13]  E. Martz,et al.  CTL: virus control cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis. , 1989, Immunology today.

[14]  L. Gooding,et al.  Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Gooding,et al.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. , 1988, Journal of immunology.

[16]  H. Shin,et al.  Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation. , 1988, Journal of immunology.

[17]  H. Holtmann,et al.  Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells. , 1988, Journal of immunology.

[18]  H. Kuriyama,et al.  Self-induction of defense against tumor necrosis factor cytotoxicity in tumor cells and normal cells. , 1988, Immunopharmacology and immunotoxicology.

[19]  J. Cohen,et al.  Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. , 1987, Journal of immunology.

[20]  S. Jackson,et al.  Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. , 1987, Immunology.

[21]  R. Hornung,et al.  Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor. , 1987, Lymphokine research.

[22]  F. Balkwill,et al.  DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon‐γ , 1987, European journal of immunology.

[23]  A. Wyllie,et al.  Death and the cell. , 1986, Immunology today.

[24]  J. Tite,et al.  DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Sidoli,et al.  Expression of the human apolipoprotein AI gene fused to the E. coli gene for β‐galactosidase , 1986, FEBS Letters.

[26]  J. Cidlowski,et al.  Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. , 1986, Endocrinology.

[27]  J. Kerr,et al.  Apoptosis, lymphocytotoxicity and the containment of viral infections. , 1985, Medical hypotheses.

[28]  Z. Eshhar,et al.  Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Olson,et al.  DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system. , 1985, Advances in experimental medicine and biology.

[30]  P. Henkart,et al.  Mechanisms of Cell-Mediated Cytotoxicity II , 1985, Advances in Experimental Medicine and Biology.

[31]  J. Cohen,et al.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.

[32]  J. Cohen,et al.  Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Russell,et al.  Mechanisms of immune lysis. III. Characterization of the nature and kinetics of the cytotoxic T lymphocyte-induced nuclear lesion in the target. , 1982, Journal of immunology.

[34]  P. Cuatrecasas,et al.  Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. , 1981, Cancer research.

[35]  A. Wyllie Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.

[36]  J. Russell,et al.  Mechanisms of immune lysis. I. Physiological distinction between target cell death mediated by cytotoxic T lymphocytes and antibody plus complement. , 1980, Journal of immunology.

[37]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.